OTC Ingredient Contamination Facing More Stringent FDA Scrutiny
This article was originally published in The Tan Sheet
Executive Summary
FDA may be heightening its vigilance over OTC active pharmaceutical ingredients with regard to potential contamination, FDA's New Jersey district director said Aug. 27.